Publi­ca­tions and analyses on the Tareno Health­care Funds

The Tareno Impact Health­care Fund invests in compa­nies that make a concrete contri­bu­tion to SDG 3, “Good Health and Well-being.” The focus is on solutions that improve access to health care, streng­then preven­tion, and enable socially relevant innova­tions.

The health­care sector continued its positive perfor­mance in August and once again outper­formed the global equity markets. Positive clinical data, strong quarterly results and brisk M&A activity provided further momentum.

Health­care is much more than just a defen­sive compo­nent of a portfolio. The Tareno Sustainable Health­care Fund invests globally in select high-quality compa­nies that benefit from long-term growth drivers and contri­bute to more efficient health­care through innova­tive solutions.

The health­care sector continued its positive perfor­mance in July and once again outper­formed global stock markets. This perfor­mance was driven by an ongoing rotation into the health­care sector, numerous M&A transac­tions, and a strong second-quarter earnings season.

With a return of +5.0%, the health­care sector performed well in June and signi­fi­cantly outper­formed global stock markets. This perfor­mance was driven by a rotation into the health­care sector, robust M&A activity, and positive momentum from research and regula­tion.

With a return of +1.9%, the health­care sector performed positively in May. The perfor­mance was driven by a strong reporting season, numerous takeovers and progress in the pharmaceu­ti­cals, life sciences and medical techno­logy sectors. The Tareno Health­care Funds also benefited from this environ­ment and achieved a pleasing perfor­mance.

The health­care sector ended April on a slightly negative note, charac­te­rized by geopo­li­tical develo­p­ments, political uncer­tain­ties and ongoing market volati­lity. At the same time, strong corpo­rate figures, high M&A activity and progress in the area of obesity thera­pies provided support in selected segments. The Tareno Health­care Funds benefited in parti­cular from their selec­tive positio­ning in the managed care and pharmaceu­tical sectors.

The health­care sector gained 2.9% in February, outper­forming the global equity markets with a gain of 0.7%. The month was charac­te­rized by the reporting season, news on obesity studies, AI disrup­tion fears and renewed “flight-to-safety” momentum.

The health­care sector gained 2.9% in February, outper­forming the global equity markets with a gain of 0.7%. The month was charac­te­rized by the reporting season, news on obesity studies, AI disrup­tion fears and renewed “flight-to-safety” momentum.

January was an eventful month for the health­care sector, marked by the JPMorgan Health­care Confe­rence, political develo­p­ments and the start of the reporting season. Read how these factors influenced the market develo­p­ment, the portfolio orien­ta­tion and the perfor­mance of the Tareno Health­care Funds.

The health­care sector remained charac­te­rized by political and regula­tory uncer­tainty in December and under­per­formed the global equity market. Pharma was the only robust sub-sector, while M&A activi­ties and increased IPO momentum provided selec­tive impetus. The Tareno Health­care Funds responded with targeted portfolio adjust­ments and diffe­ren­tiated positio­ning.